+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prevalence of endometrial injury in asymptomatic obese women

Prevalence of endometrial injury in asymptomatic obese women

Revista Da Associacao Medica Brasileira 53(4): 344-348

Obesity represents the most important risk factor for endometrial pathology. This study aimed to evaluate the prevalence of endometrial injuries, such as polyps, hyperplasia and endometrial cancer in asymptomatic obese women, as well as to recognize the associated risk factors . A cross-sectional study was conducted between December 2004 and February 2006. Ninety-four obese (body mass index > or = 30 kg/m2) women were evaluated, divided in two groups of 47 participants each: pre-menopausal and postmenopausal women. Clinical characteristics, physical exams (anthropometric and gynecological), blood count and endometrial assessment by vaginal ultrasonography, biopsy, and hysteroscopy (only for confirmed endometrial pathology), were the variables appraised. In pre-menopausal women, 12.8% of cases had endometrial pathology statistically associated to age, hypertension, hypercholesterolemia and LDL-c increase. In the post-menopausal women, 40.4% of cases had a pathology identified as statistically associated with hypertension, LDL-c and estrone increase. Two cases of endometrial cancer were identified, one in each group. The increased incidence of obesity over recent years has increased risk factors of endometrial cancer. In pre-menopausal women only a small number of cases with endometrial alterations was observed. Therefore, it is suggested that greater attention be given to those over 40 years of age, associated with hypertension and/or higher LDL-c . The menopausal status increases risk of endometrial injury, and when associated with hypertension, LDL-c and/or estrone increase, women become candidates to biopsy aiming for an early diagnosis of cancer, a decisive factor for a favorable prognosis.

(PDF emailed within 1 workday: $29.90)

Accession: 055157530

Download citation: RISBibTeXText

PMID: 17823739

Related references

Bariatric surgery and endometrial pathology in asymptomatic morbidly obese women: a prospective, pilot study. Bjog 120(7): 795-800, 2013

Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women. Australian & New Zealand Journal of Obstetrics & Gynaecology 48(2): 207-213, 2008

The role of endometrial thickness for detecting endometrial pathologies in asymptomatic postmenopausal women. Australian & New Zealand Journal of Obstetrics & Gynaecology 54(1): 36-40, 2014

The utility of endometrial thickness measurement in asymptomatic postmenopausal women with endometrial fluid. Journal of Obstetrics and Gynaecology 36(2): 230-233, 2015

Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. Journal of Clinical Oncology 17(7): 2050-2054, 1999

Normal appearing endometrial cells in cervical smears of asymptomatic postmenopausal women have predictive value for significant endometrial pathology. International Journal of Gynecological Cancer 16(3): 1069-1074, 2006

Capacity of endometrial thickness measurement to diagnose endometrial carcinoma in asymptomatic postmenopausal women: a systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology 40(6): 621-629, 2013

Evaluation of the diagnostic role of transvaginal ultrasound measurements of endometrial thickness to detect endometrial malignancy in asymptomatic postmenopausal women. Archives of Gynecology and Obstetrics 294(2): 311-316, 2017

Routine endometrial sampling of asymptomatic premenopausal women shedding normal endometrial cells in Papanicolaou tests is not cost effective. Cancer 111(1): 26-33, 2007

The capacity of endometrial thickness measurement to diagnose endometrial carcinoma in asymptomatic postmenopausal women a systematic review and meta analysis. 2012

Serum adiponectin in relation to endometrial cancer and endometrial hyperplasia with atypia in obese women. European Journal of Gynaecological Oncology 29(6): 594-597, 2009

Association of endometrial thickness assessed at trans-vaginal ultrasonography to endometrial cancer in postmenopausal women asymptomatic or with abnormal uterine bleeding. La Radiologia Medica 104(5-6): 437-442, 2003

Comparison of serum androgens and endometrial thickness in obese and non-obese postmenopausal women. Journal of the Turkish German Gynecological Association 11(3): 149-151, 2010

Total laparoscopic hysterectomy for early stage endometrial cancer in obese and morbidly obese women. Journal of Obstetrics and Gynaecology 32(6): 580-584, 2012

Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women. Gynecological Endocrinology 29(2): 156-159, 2013